Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Good Morning! Latin America.
Press releases published on August 27, 2025
Nautilus Biotechnology to Participate in Upcoming September Investor Conferences
GlobeNewswire
·
August 27, 2025
SEATTLE, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the following investor conferences …
EZ LYNK Puts Power Back in Drivers’ Hands with Ford Super Duty Update Support Now Available via OBD
GlobeNewswire
·
August 27, 2025
GEORGE TOWN, Cayman Islands, Aug. 27, 2025 (GLOBE NEWSWIRE) -- EZ LYNK, a leader in connected vehicle technologies, today announced the availability of software update support via the On-Board Diagnostics (OBD) port for Ford’s 2020–2025 Super Duty platform …
Context Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
PHILADELPHIA, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced that the …
BridgeBio to Participate in September Investor Conferences
GlobeNewswire
·
August 27, 2025
PALO ALTO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that members of its management team will host …
Pasinex Announces Q2 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 27, 2025
TORONTO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Pasinex Resources Limited (CSE: PSE) (FSE: PNX) ("Pasinex" or the "Company") today announced financial results for the second quarter ended June 30, 2025. The financial statements, management’s discussion and …
Minovia Therapeutics מודיעה על מענק של 350,000 דולר מקרןCountdown for a Cure לפיתוח סמנים ביולוגיים מבוססי דם של מיטוכונדריה
GlobeNewswire
·
August 27, 2025
חיפה, ישראל, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Minovia Therapeutics Ltd("מינוביה" או "החברה"), חברת ביוטכנולוגיה בשלבים קליניים המפתחת טיפולים חדשניים לטיפול במחלות מיטוכונדריאליות ולמאבק בהידרדרות הקשורה לגיל, מודיעה כי נבחרה לקבל מענק של 350,000 דולר מ- …
Ventyx Biosciences to Participate in Three Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for patients with autoimmune, inflammatory, and …
Invivyd to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
WALTHAM, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that it will present at the following investor conferences: Cantor Global Healthcare Conference 2025 Fireside Chat Date: Wednesday, September 3, 2025 Fireside …
Quell Therapeutics Establishes World-Class Scientific Advisory Board
GlobeNewswire
·
August 27, 2025
London, UK – 27 August, 2025 – Quell Therapeutics Ltd (“Quell”), a pioneer in engineered T-regulatory (Treg) cell therapies for people with immune-mediated diseases, announces the formation of its Scientific Advisory Board (SAB). The SAB comprises globally …
Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
WALTHAM, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that management will participate in webcast fireside chats at the following investor conferences: Wells Fargo Healthcare Conference Date/Time: …
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences
GlobeNewswire
·
August 27, 2025
CAMBRIDGE, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- August 27, 2025 -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, …
Ocular Therapeutix™ to Participate in September Investor and Scientific Conferences
GlobeNewswire
·
August 27, 2025
BEDFORD, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced participation in several upcoming investor and …
Mesoblast Financial Results and Corporate Update Webcast
GlobeNewswire
·
August 27, 2025
NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast to discuss operational highlights and financial results for the full year …
Bitget Wallet Launches Native Gas-Free Transactions Across Arbitrum, Solana, and TRON
GlobeNewswire
·
August 27, 2025
SAN SALVADOR, El Salvador, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Bitget Wallet, a non-custodial multi-chain crypto wallet, has introduced support for gas-free transactions on the Arbitrum network, expanding its existing gas-free coverage to include Solana and …
Bitget Brings the Bull to Bali at Coinfest Asia 2025
GlobeNewswire
·
August 27, 2025
BALI, Indonesia, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Bitget, the leading cryptocurrency exchange and Web3 company, has successfully concluded its participation at Coinfest Asia 2025, held at Nuanu Creative City, Bali, from 21 to 22 August. As one of the …
Bitget Launchpool to list Bitlayer (BTR) with over 2.7M in Token Rewards
GlobeNewswire
·
August 27, 2025
VICTORIA, Seychelles, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Bitget, the leading cryptocurrency exchange and Web3 company, has announced the listing of Bitlayer (BTR) in the Innovation Zone, adding it for spot trading. Deposits for the BTR/USDT will open on 27 …
Bitget publica prueba de reservas de agosto de 2025, y mantiene un índice de reservas del 188 %
GlobeNewswire
·
August 27, 2025
VICTORIA, Seychelles, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Bitget, la principal bolsa de criptomonedas y empresa Web3, publicó su informe de prueba de reservas para agosto de 2025 Informe de prueba de reservas (PoR, por sus siglas en inglés), y reafirma su …
Bitget publie son rapport de preuve de réserves pour août 2025, à raison d’un ratio de réserve établi à 188 %
GlobeNewswire
·
August 27, 2025
VICTORIA, Seychelles, 27 août 2025 (GLOBE NEWSWIRE) -- Bitget, première bourse de cryptomonnaies et société Web3 au monde, publie l’édition d’août 2025 de son rapport de preuve de réserves (ou PoR, de l’anglais Proof of Reserves) et réitère son engagement …
Bitget פרסמה את הוכחת העתודות שלה לאוגוסט 2025 - שומרת על יחס עתודות של 188%
GlobeNewswire
·
August 27, 2025
ויקטוריה, איי סיישל, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Bitget, בורסת המטבעות הקריפטוגרפים המובילה וחברת Web3, פרסמה את דו"ח הוכחת הרזרבות (PoR) שלה לאוגוסט 2025, והוא מאשרר מחדש את מחויבותה לשקיפות ולהגנה על המשתמשים. הנתונים האחרונים מראים ש-Bitget ממשיכה …
ビットゲット (Bitget)、2025年8月版準備金証明 (Proof of Reserves) を公開、188％の準備金比率を維持
GlobeNewswire
·
August 27, 2025
セーシェル・ビクトリア発, Aug. 27, 2025 (GLOBE NEWSWIRE) -- 暗号資産取引所およびWeb3企業の大手であるビットゲットは、2025年8月の準備金証明 (PoR) レポートを公開し、透明性とユーザー保護への取り組みを改めて示した。 最新データによれば、ビットゲットは主要資産において合計188％という業界標準を大きく上回る準備金比率を引き続き維持している。 2025年8月22日時点で、ビットゲットはユーザー資産7,681.36 BTCに対して28,022.72 BTC …